521 related articles for article (PubMed ID: 24923260)
1. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma.
George S; Barysauskas C; Serrano C; Oduyebo T; Rauh-Hain JA; Del Carmen MG; Demetri GD; Muto MG
Cancer; 2014 Oct; 120(20):3154-8. PubMed ID: 24923260
[TBL] [Abstract][Full Text] [Related]
2. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
Oduyebo T; Rauh-Hain AJ; Meserve EE; Seidman MA; Hinchcliff E; George S; Quade B; Nucci MR; Del Carmen MG; Muto MG
Gynecol Oncol; 2014 Feb; 132(2):360-5. PubMed ID: 24296345
[TBL] [Abstract][Full Text] [Related]
3. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389
[TBL] [Abstract][Full Text] [Related]
4. Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis.
Bogani G; Cliby WA; Aletti GD
Gynecol Oncol; 2015 Apr; 137(1):167-72. PubMed ID: 25462199
[TBL] [Abstract][Full Text] [Related]
5. The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome.
Pedra Nobre S; Hensley ML; So M; Zhou QC; Iasonos A; Leitao MM; Ducie J; Chiang S; Mueller JJ; Abu-Rustum NR; Zivanovic O
Gynecol Oncol; 2021 Jan; 160(1):99-105. PubMed ID: 33158511
[TBL] [Abstract][Full Text] [Related]
6. Incidental power morcellation of malignancy: a retrospective cohort study.
Graebe K; Garcia-Soto A; Aziz M; Valarezo V; Heller PB; Tchabo N; Tobias DH; Salamon C; Ramieri J; Dise C; Slomovitz BM
Gynecol Oncol; 2015 Feb; 136(2):274-7. PubMed ID: 25740603
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome affected by tumor morcellation in unexpected early uterine leiomyosarcoma.
Lin KH; Torng PL; Tsai KH; Shih HJ; Chen CL
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):172-7. PubMed ID: 25951723
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Occult Uterine Sarcoma Among Women Undergoing Minimally Invasive Gynecologic Surgery.
Oduyebo T; Hinchcliff E; Meserve EE; Seidman MA; Quade BJ; Rauh-Hain JA; George S; Nucci MR; del Carmen MG; Muto MG
J Minim Invasive Gynecol; 2016 Jan; 23(1):34-9. PubMed ID: 26253281
[TBL] [Abstract][Full Text] [Related]
9. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive Surgery and HIPEC as a Treatment Option for Laparoscopic Resection of Uterine Leiomyosarcoma with Morcellation: Early Results.
Sugarbaker P; Ihemelandu C; Bijelic L
Ann Surg Oncol; 2016 May; 23(5):1501-7. PubMed ID: 26545375
[TBL] [Abstract][Full Text] [Related]
11. [Hysterectomies performed for presumed leiomyomas: should the fear of leiomyosarcoma make us apprehend non laparotomic surgical routes?].
Leung F; Terzibachian JJ; Gay C; Chung Fat B; Aouar Z; Lassabe C; Maillet R; Riethmuller D
Gynecol Obstet Fertil; 2009 Feb; 37(2):109-14. PubMed ID: 19200764
[TBL] [Abstract][Full Text] [Related]
12. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.
Skorstad M; Kent A; Lieng M
Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
[TBL] [Abstract][Full Text] [Related]
14. A Retrospective Analysis of the Impact of Myomectomy on Survival in Uterine Sarcoma.
Gao Z; Li L; Meng Y
PLoS One; 2016; 11(2):e0148050. PubMed ID: 26828206
[TBL] [Abstract][Full Text] [Related]
15. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study.
Raspagliesi F; Maltese G; Bogani G; Fucà G; Lepori S; De Iaco P; Perrone M; Scambia G; Cormio G; Bogliolo S; Bergamini A; Bifulco G; Casali PG; Lorusso D
Gynecol Oncol; 2017 Jan; 144(1):90-95. PubMed ID: 27817933
[TBL] [Abstract][Full Text] [Related]
16. ACOG Committee Opinion No. 770 Summary: Uterine Morcellation for Presumed Leiomyomas.
Obstet Gynecol; 2019 Mar; 133(3):604-605. PubMed ID: 30801469
[TBL] [Abstract][Full Text] [Related]
17. ACOG Committee Opinion No. 770: Uterine Morcellation for Presumed Leiomyomas.
Obstet Gynecol; 2019 Mar; 133(3):e238-e248. PubMed ID: 30801477
[TBL] [Abstract][Full Text] [Related]
18. Incidence and groups at risk for unexpected uterine leiomyosarcoma: a Dutch nationwide cohort study.
van den Haak L; de Kroon CD; Warmerdam MI; Siebers AG; Rhemrev JP; Nieboer TE; Jansen FW
Arch Gynecol Obstet; 2019 Jan; 299(1):159-165. PubMed ID: 30498966
[TBL] [Abstract][Full Text] [Related]
19. Effects of morcellation on long-term outcomes in patients with uterine leiomyosarcoma.
Nemec W; Inwald EC; Buchholz S; Klinkhammer Schalke M; Gerken M; Ortmann O
Arch Gynecol Obstet; 2016 Oct; 294(4):825-31. PubMed ID: 27105972
[TBL] [Abstract][Full Text] [Related]
20. No. 371-Morcellation During Gynaecologic Surgery: Its Uses, Complications, and Risks of Unsuspected Malignancy.
Murji A; Scott S; Singh SS; Bougie O; Leyland N; Laberge PY; Vilos GA
J Obstet Gynaecol Can; 2019 Jan; 41(1):116-126. PubMed ID: 30580824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
